Social networks
766 2,359Entity types
Location
101 S Hanley Rd #1850, St. Louis, MO 63105, USA
St. Louis
United States of America
Employees
Scale: 11-50
Estimated: 16
Engaged corporates
4Added in Motherbase
3 years agoA leading venture capital firm building life science companies to address significant unmet medical needs
RiverVest Venture Partners® is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investors.
With headquarters in St. Louis and offices in San Diego and Cleveland, RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies.
Entrepreneurs turn to RiverVest for the scientific, operational, financial, and investment expertise they need to achieve long-term success. RiverVest is committed to doing business the right way to deliver the best outcomes for patients, entrepreneurs and investors.
Established in 2000, RiverVest has funded more than 60 innovative life science companies and has assets under management of approximately $750 million. For more information, please visit http://www.rivervest.com.
Medical Device Venture Capital, Life sciences Venture Capital, and Biopharma Venture Capital
RiverVest is a leading venture capital firm building life science companies to address significant unmet medical needs.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Other 14 Sep 2022 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 31 Oct 2023 | | |
FirstWord Pharma Pharmaceutical, Pharmaceutical Manufacturing | FirstWord Pharma Pharmaceutical, Pharmaceutical Manufacturing | Other 13 Aug 2014 | | |
The Yield Lab Venture Capital and Private Equity Principals | The Yield Lab Venture Capital and Private Equity Principals | Other 20 Oct 2015 | |